المؤلفون: Kiladjian J. -J., Zachee P., Hino M., Pane F., Masszi T., Harrison C. N., Mesa R., Miller C. B., Passamonti F., Durrant S., Griesshammer M., Kirito K., Besses C., Moiraghi B., Rumi E., Rosti V., Blau I. W., Francillard N., Dong T., Wroclawska M., Vannucchi A. M., Verstovsek S.

المساهمون: J.-. Kiladjian, P. Zachee, M. Hino, F. Pane, T. Masszi, C.N. Harrison, R. Mesa, C.B. Miller, F. Passamonti, S. Durrant, M. Griesshammer, K. Kirito, C. Besse, B. Moiraghi, E. Rumi, V. Rosti, I.W. Blau, N. Francillard, T. Dong, M. Wroclawska, A.M. Vannucchi, S. Verstovsek

مصطلحات موضوعية: Settore MED/15 - Malattie del Sangue

Relation: info:eu-repo/semantics/altIdentifier/pmid/31982039; info:eu-repo/semantics/altIdentifier/wos/WOS:000515522000016; volume:7; issue:3; firstpage:e226; lastpage:e237; numberofpages:12; journal:THE LANCET. HAEMATOLOGY; https://hdl.handle.net/2434/998568; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85079894730

الاتاحة: https://hdl.handle.net/2434/998568
https://doi.org/10.1016/S2352-3026(19)30207-8

المؤلفون: Vannucchi, AM, te Boekhorst, Peter, Harrison, CN, He, GS, Caramella, M, Niederwieser, D, Boyer-Perrard, F, Duan, MH, Francillard, N, Molloy, B, Wroclawska, M, Gisslinger, H

المصدر: Vannucchi , AM , te Boekhorst , P , Harrison , CN , He , GS , Caramella , M , Niederwieser , D , Boyer-Perrard , F , Duan , MH , Francillard , N , Molloy , B , Wroclawska , M & Gisslinger , H 2019 , ' EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis ' , Haematologica , vol. 104 , no. 5 , pp. 947-954 . https://doi.org/10.3324/haematol.2018.204602

مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM024104, name=EMC MM-02-41-04

وصف الملف: application/pdf

الاتاحة: https://pure.eur.nl/en/publications/b939f552-eafc-4232-b060-2d69f8feed8f
https://doi.org/10.3324/haematol.2018.204602
https://pure.eur.nl/ws/files/48192730/Repub_116826_O-A.pdf
http://hdl.handle.net/1765/116826

المؤلفون: Barraco, F., Greil, R., Herbrecht, R., Schmidt, H. Burkhard, Reiter, A., Willenbacher, W., Raymakers, R., Liersch, R., Wroclawska, M., Pack, R., Burock, K., Levine, M., Gisslinger, H.

المصدر: HemaSphere ; volume 3, issue S1, page 293-294 ; ISSN 2572-9241 2572-9241

الاتاحة: http://dx.doi.org/10.1097/01.hs9.0000561000.29259.89
https://onlinelibrary.wiley.com/doi/pdf/10.1097/01.HS9.0000561000.29259.89

المؤلفون: Vannucchi, AM, Boekhorst, P.A.W. (Peter) te, Harrison, CN, He, G.S., Caramella, M., Niederwieser, D. (Dietger), Boyer-Perrard, F., Duan, M.H., Francillard, N., Molloy, B., Wroclawska, M., Gisslinger, H.

مصطلحات الفهرس: info:eu-repo/semantics/article

URL: http://repub.eur.nl/pub/116826

المؤلفون: Elisa Rumi, Tamás Masszi, Ruben A. Mesa, Jean-Jacques Kiladjian, Francesco Passamonti, Tuochuan Dong, Nathalie Francillard, Vittorio Rosti, Srdan Verstovsek, Beatriz Moiraghi, Carlos Besses, Simon Durrant, Masayuki Hino, Pierre Zachee, Fabrizio Pane, Claire N. Harrison, Martin Griesshammer, Alessandro M. Vannucchi, Monika Wroclawska, Keita Kirito, Carole B. Miller, Igor Wolfgang Blau

المساهمون: Kiladjian, J. -J., Zachee, P., Hino, M., Pane, F., Masszi, T., Harrison, C. N., Mesa, R., Miller, C. B., Passamonti, F., Durrant, S., Griesshammer, M., Kirito, K., Besses, C., Moiraghi, B., Rumi, E., Rosti, V., Blau, I. W., Francillard, N., Dong, T., Wroclawska, M., Vannucchi, A. M., Verstovsek, S.

المصدر: Lancet Haematol

مصطلحات موضوعية: Ruxolitinib, Time Factors, Polyethylene Glycol, Polyethylene Glycols, 0302 clinical medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Hydroxyurea, Medicine, Polycythemia Vera, education.field_of_study, Fibrinolytic Agent, Pipobroman, Hematology, Recombinant Protein, Prognosis, Recombinant Proteins, Survival Rate, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Human, medicine.drug, medicine.medical_specialty, Polycythaemia, Prognosi, Population, Interferon alpha-2, Antiviral Agents, Article, Follow-Up Studie, 03 medical and health sciences, Pharmacotherapy, Fibrinolytic Agents, Internal medicine, Nitriles, Humans, Adverse effect, education, Survival rate, Antiviral Agent, Antineoplastic Combined Chemotherapy Protocol, business.industry, Quinazoline, Interferon-alpha, Anagrelide, medicine.disease, Pyrimidines, Pyrazole, Quinazolines, Pyrazoles, business, Follow-Up Studies, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ff87043c8325ec081c2cc7c6f93aed
https://doi.org/10.1016/s2352-3026(19)30207-8